LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma

NCT00161239 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

64

Enrollment

OTHER

Sponsor class

Stopped toxicity

Conditions

T-Cell Lymphoma

Interventions

DRUG: Doxil, Methotrexate, L-Asparaginase, Prednisone

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]